已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Prognostic value and clinical usefulness of PIANO score in patients undergoing primary percutaneous coronary intervention

医学 传统PCI 经皮冠状动脉介入治疗 危险系数 内科学 临床终点 心肌梗塞 心脏病学 人口 置信区间 外科 临床试验 环境卫生
作者
Chunfeng Dai,Zheng Yang,Muyin Liu,You Zhou,Danbo Lu,Shufu Chang,Chenguang Li,Hao Lu,Zhangwei Chen,Juying Qian,Junbo Ge
出处
期刊:International Journal of Cardiology [Elsevier]
卷期号:390: 131258-131258 被引量:2
标识
DOI:10.1016/j.ijcard.2023.131258
摘要

Background In our previous study, the PIANO score was constructed to predict the occurrence of no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PCI). In the current analysis, we sought to evaluate the prognostic value and clinical usefulness of the PIANO score in this population. Methods Patients with acute myocardial infarction (AMI) undergoing primary PCI were consecutively enrolled and followed up in this register. The endpoint of interest was all-cause mortality at 2 years after the procedure. The clinical benefits of thrombus aspiration (TA) during primary PCI in certain subgroups were also evaluated as exploratory analyses. Results A total of 2100 patients were identified, and 54.3% had high (≥8) PIANO score. After 2-year follow-up, patients with high PIANO score had higher risk of all-cause mortality after adjustment for propensity score (6.7% vs. 3.1%, adjusted hazard ratio = 2.11 [1.21–3.68], p = 0.008), especially in the first month (adjusted hazard ratio = 2.33 [1.17–4.65], p = 0.017). Restricted cubic spline analysis indicated the linear association between the PIANO score and 2-year all-cause mortality (nonlinear p = 0.556). Further analysis demonstrated that TA did not reduce all-cause mortality in the overall patients, as well as in those with visible thrombus, high thrombus burden, or occlusive lesions. However, the PIANO score defined "high-risk" (PIANO score ≥ 8) patients could benefit from it. Conclusions The PIANO score had potential prognostic value in patients with AMI undergoing primary PCI. It might also be helpful for identifying patients who would benefit from TA. These observations require further confirmation in future studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
肉松完成签到,获得积分10
3秒前
4秒前
6秒前
橘橘橘子皮完成签到 ,获得积分10
7秒前
充电宝应助起风了采纳,获得10
8秒前
zxr发布了新的文献求助10
13秒前
Akim应助美满的天薇采纳,获得10
16秒前
kyt发布了新的文献求助30
17秒前
17秒前
Singularity应助LJT采纳,获得10
18秒前
杳鸢应助kento采纳,获得100
19秒前
笨笨西牛完成签到 ,获得积分10
22秒前
22秒前
大模型应助coll88采纳,获得10
23秒前
Singularity应助从容之云采纳,获得10
24秒前
含蓄的明雪应助木叶采纳,获得10
25秒前
嗯哼应助只为春庭月采纳,获得10
25秒前
zz完成签到 ,获得积分10
26秒前
华仔应助野性的凌瑶采纳,获得10
26秒前
27秒前
27秒前
27秒前
27秒前
oceanao应助kyt采纳,获得10
28秒前
30秒前
司空蓝发布了新的文献求助10
32秒前
33秒前
akito发布了新的文献求助10
33秒前
要努力坚持啊完成签到,获得积分10
33秒前
超帅的dz发布了新的文献求助10
33秒前
38秒前
酷波er应助超帅的dz采纳,获得10
38秒前
华仔应助科研通管家采纳,获得10
38秒前
852应助科研通管家采纳,获得10
38秒前
李健应助科研通管家采纳,获得10
38秒前
科目三应助科研通管家采纳,获得10
38秒前
田様应助科研通管家采纳,获得30
39秒前
居居应助科研通管家采纳,获得10
39秒前
英姑应助科研通管家采纳,获得30
39秒前
JamesPei应助科研通管家采纳,获得10
39秒前
高分求助中
Evolution 10000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Distribution Dependent Stochastic Differential Equations 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3158461
求助须知:如何正确求助?哪些是违规求助? 2809636
关于积分的说明 7882903
捐赠科研通 2468254
什么是DOI,文献DOI怎么找? 1314017
科研通“疑难数据库(出版商)”最低求助积分说明 630572
版权声明 601956